Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

98 results found in London, UK

Sort by:
Showing 11 - 20 of 98 results
Expert in: Oncology
25 years of experience

Martin graduated from the University of Newcastle upon Tyne and gained general medical experience in New Zealand, Australia and the United Kingdom, becoming a member of the Royal College of Physicians (UK) in 2000. Since then he has been working in cancer care, training in Medical Oncology at the Oxford Radcliffe and Royal Marsden NHS Trusts. During this time, he achieved a PhD at the Institute for Cancer Research, London, and was awarded the EORTC-PAMM Young Investigator Award in 2004. He completed his specialist training in Medical Oncology in 2008 and was appointed as a UCL Clinical Senior Lecturer and UCH Consultant in Medical Oncology in 2009. Since then he has been running a research-based practice and has been principal/chief investigator for more than 20 early and late phase clinical trials.

Martin is involved in the management of patients with both lung and head and neck cancers. He is interested in drug development and in using the increasing understanding of cancer biology to design studies that distinguish patient populations most likely to gain benefit from new drugs and new drug combinations. He has a particular interest in cancer biology that leads to the development of both lung and head and neck cancers.

Read more
Expert in: Oncology
18 years of experience
Clinical Oncology

Dr John Conibear graduated from the University Hospital of Wales in 2001 and completed his post-graduate general medical training in The Barts and The London Training rotation in 2006. Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital. During his fellowship, he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded an MD(Res) from UCL in 2018.

He is currently deputy medical director and deputy director of Barts Cancer Centre. Dr Conibear specialises in all the non-surgical treatments for both lung and breast cancers. He has expertise in chemotherapy, biological therapy, immunotherapy, radiotherapy and state of the art radiotherapy techniques including deep inspiration breath-hold (DIBH) for early breast cancer, Intensity Modulated Radiotherapy (IMRT), Image-Guided Radiotherapy (IGRT), 4D-CT and both Cyberknife and Gamma Knife (stereotactic radiotherapy). He is also currently the lead for chemotherapy and clinical director for thoracic oncology in St. Bartholomew’s Hospital.

Read more
Expert in: Oncology
16 years of experience
Medical Oncology

Dr Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare at numerous locations including Sarah Cannon Research Institute, The Harley Street Clinic, The Princess Grace and The Wellington Hospital. Additionally, he holds an NHS post at University College London Hospital where he is a Professorial Research Associate. 

He is a founding Medical Director of the Sarah Cannon Research Institute UK and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. The talented physician has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. 

He was awarded his medical degree from Hanover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his reserach contributions to his field. During his career, he has published numerous peer reviewed articals and book chapters and contributes regulalry at international meetings such as ASCO, ESMO and AACR. He is leading the Sarah Cannon Institute UK as a Chief and Principal Investigator of numerous clinical trials of new anti-cancer drugs including immunotherapies and cellular therapies.

Read more
Expert in: Oncology
34 years of experience

Dr Katharine Pigott graduated from the University of London in 1995 having trained at The Middlesex Hospital. She specialised in Clinical Oncology training at The Westminster Hospital and Charing Cross Hospital. She also spent two years working as a research fellow at Mount Vernon Hospital and the Gray Laboratory running clinical trials in hyper fractionation and undertaking an MD in measuring late radiation damage. She took up a consultant post at The Royal Free in 1996 and worked there for twenty years specialising in the management and treatment of urological cancers and breast cancer.

During her time at The Royal Free, she was head of the Radiotherapy Department and Chair of The London Cancer Radiotherapy Expert Reference Group. Her clinical interests are research in breast and prostate cancer particularly in new radiotherapy technique and clinical trials. She was the radiotherapy lead for the TARGIT Academy at The Royal Free which taught intraoperative radiotherapy (IORT) to centres throughout the world and participated in the TARGIT trials.

She has published peer-review papers and co-edited books on the urological condition and intraoperative radiotherapy.

Read more
Expert in: Oncology
18 years of experience

Dr Timothy Robert Crook is a Consultant in Medical Oncology who works at The Princess Grace Hospital, The Harley Street Clinic, The Wellington Hospital and LOC.

He specialises in Bladder cancer, breast disease, chemotherapy, kidney cancer, oncology and skin cancer.

Read more
Expert in: Oncology
42 years of experience

Dr Maurice Slevin graduated from the University of Cape Town in South Africa and subsequently worked for four years at the world-famous Groote Schuur Hospital before coming to the UK, practising for almost 30 years in the Department of Medical Oncology at London’s St Bartholomew’s Hospital.

His special interests include Colon Cancer, Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer and Stomach Cancer.

Read more
Expert in: Oncology
33 years of experience

Professor John Bridgewater is a Consultant Medical Oncologist and Clinical Researcher at the UCL Cancer Institute. He specialises in gastrointestinal oncology, with a particular interest in biliary tract cancers and carcinomas of unknown primary origin.

After studying medicine at Oxford and University College London, he went on to specialise in Medical Oncology at the Middlesex, Mount Vernon and Royal Marsden Hospital. He was awarded a PhD by the Institute of Cancer Research for research into gene therapy. In 1999 he was appointed as a Senior Lecturer in Medical Oncology at UCL.

Professor Bridgewater leads the National Cancer Research Institute subgroup in hepatobiliary malignancy and also has a laboratory programme at the UCL Cancer Institute investigating carcinoma of unknown primary origin. He is also active in trials across the gastrointestinal portfolio and has been the chief investigator on a number of landmark studies into gastrointestinal and biliary tract cancers. As well as his clinical and research work, he also serves on a number of committees including The National Institute for Health and Care Excellence (NICE) and National Cancer Research Institute (NCRI). 

Read more
Expert in: Oncology
16 years of experience

Dr Jonathan Krell is a Consultant Oncologist specialising in breast and gynaecological cancers, with particular interest in cancer genetics and hereditary malignancies, especially with respect of BRCA and other gene mutations. His clinical focus is on the systemic management of patients with gynaecological and breast cancers. 

Dr Krell qualified in medicine at Leeds University Medical School, where he also gained a first class honours degree in Pharmacology. He completed junior doctor positions at St James’ Hospital, Leeds and St Thomas’ Hospitals in London. He then undertook oncology training at Charing Cross and Hammersmith Hospitals.

His PhD work was funded by the Medical Research Council and this investigated the interplay between genetic mutations, DNA damage and the response to cancer therapeutics. Dr Krell is a leading member of the translational research team within the Cancer Research UK and Ovarian Cancer Action centres at Imperial College that aim to overcome resistance to current anti-cancer agents in ovarian and breast cancer.

Dr Krell has published more than 100 peer-reviewed papers in academic journals and he regularly presents on his research at national and international conferences.

 

Read more
Dr Amen Sibtain

Dr Amen Sibtain

1.27 miles

Dr Amen Sibtain

1.27 miles
Expert in: Oncology
28 years of experience

Dr Amen Sibtain is a Consultant Clinical Oncologist, practicing at a number of clinics in London. He specialises in the management of Gastrointestinal, Hepatobiliary and Head and Neck cancers with chemotherapy and radiotherapy. He is also highly experienced in chemo-radiotherapy, state of the art radiotherapy techniques, including VMAT, stereotactic radiotherapy and radiosurgery, and intraoperative radiotherapy.

Dr Sibtain previously worked at the Royal Marsden, Mount Vernon and The Middlesex Hospitals, before he took up his post at Barts. He was awarded a MD degree for his research in tumour hypoxia by the University of London.

Dr Sibtain was previously President of the Oncology Section of the Royal Society of Medicine, Programme Director for Clinical Oncology Specialist Training Committee for the London Deanery and Chairman of the Head and Neck Tumour Board for North East London. He is presently the Clinical director of GI oncology and Radiotherapy at St Bartholomew’s Hospital, an examiner in oncology for the Royal College of Radiologists, a member of the medical advisory panel for both Macmillan and CRUK , oncology advisor for BBC Drama and the Clinical Lead in Head and Neck Cancer at Barts.

As well as his clinical work he is actively involved in research. He has been published in a number of peer reviewed journals and edited the books Towards the Prevention of Cancer (2007) and Physics for Clinical Oncologists (2012).

Read more
Expert in: Oncology
27 years of experience

Dr Susan Cleator is a Consultant Clinical Oncologist with extensive experience in breast, colorectal and lymphomatous cancers. She has a specialist interest in early breast cancer and treatment of breast cancer in young women.

After studying medicine at Oxford University and Hospitals, she completed her specialist oncology training at the Charing Cross, Hammersmith, Mount Vernon and The Royal Marsden Hospitals. During this time she spent three years working on her PhD project at the Institute of Cancer Research and Royal Marsden Hospital. Her research focused on identifying a molecular assay for predicting the response of breast cancers to chemotherapy.

Dr Cleator works closely with a multi-disciplinary team at St Mary’s hospital where she is responsible for the chemotherapy and radiotherapy aspect of the patient’s treatment. She is actively involved in research into both breast and colorectal cancers, and has been published in a number of peer-reviewed journals. She is also a member of a number of research groups including the National Cancer Research Institute (NCRI) Breast Cancer Studies Group (BCSG).

Read more